AEGiS-SC: OPEN FORUM: AIDS: This is no time for complacency San Francisco ChronicleImportant note: Information in this article was accurate in 2008. The state of the art may have changed since the publication date.
Click here to return to San Francisco Chronicle main menu
DonateNow


OPEN FORUM: AIDS: This is no time for complacency

San Francisco Chronicle - December 1, 2008
Jay A. Levy


This World AIDS Day coincides with the 25th anniversary of the discovery of HIV, the cause of this worldwide epidemic. In 1981, several of us faced the sudden appearance in San Francisco of a new disease entity characterized by pneumonias, cancers and a marked reduction in immune activity. When HIV was identified in 1983, at last the scientific community had a target for directing therapy and eventually a vaccine.

Yet while therapies against HIV have been developed, their distribution throughout the world is very limited. In resource-limited regions, only 5 percent of infected individuals who need the drugs are receiving these life-saving therapies. Even in those countries where antiretroviral therapy is available, the cost of treatment for a lifetime far exceeds the resources that would be provided through the industrialized countries.

Moreover, the virus continues to spread. For each new person treated, six more become infected. In the United States last year, at least 56,000 people became infected - a much greater number than was expected. About one to two people are infected in this country every 15 minutes. In San Francisco, three to four new infections occur every day.

Importantly, up to 25 percent of infected people in the United States do not know they are carrying the virus. In this regard, one must recognize that virus levels circulating in the blood may not indicate accurately the amount of virus in genital fluids. Thus, people practicing risky sexual behavior because they have very low virus levels in their blood are not making a responsible and prudent decision. All these findings portend very poorly for current approaches at treating and preventing this global epidemic.

What to do? As researchers, we must continue our efforts to find a cure for this disease and a vaccine to prevent HIV infection. We should be testing more of the public for infection since that knowledge can curtail transmission. Information about HIV/AIDS should be taught in schools, particularly the middle and high schools.

Treatment and prevention programs must be directed at controlling not only the free virus but also HIV incorporated into infected cells. A cure requires elimination of all those infected cells. Current antiretroviral therapy prevents new cell infections but does not directly affect the infected cell. In many respects, this challenge resembles cancer in which survival of just one cancer cell can begin the disease process again.

We can learn a great deal from HIV-infected people who have remained healthy at least 10 years (some 30 years) without therapy. These long-term survivors have strong antiviral immune responses, both natural and induced. They control HIV and provide insights into the correlates of protection from disease.

Obviously, the best solution for this worldwide epidemic that has affected more than 60 million people worldwide is an effective vaccine. That vaccine ideally would protect from infection and certainly the development of AIDS. Almost all current vaccines (e.g. measles, mumps, chickenpox) do not prevent the infection, but protect against development of disease.

Moreover, this AIDS vaccine should decrease viral levels in blood and genital fluids so that HIV transmission is greatly reduced, thus curtailing the epidemic. There are groups of subjects who have been exposed to HIV on many occasions without getting infected. These high-risk exposed individuals can give valuable information on defense mechanisms, mostly immune, that can be used in developing a vaccine.

Complacency about AIDS threatens our progress toward finding new directions in HIV treatment and prevention. We should quickly develop for infected individuals approaches to restore an immune system capable of controlling the virus for a lifetime. Our ultimate aim is a cure and a vaccine.

At this 25th anniversary of the identification of HIV, researchers, clinicians, public health workers, and others throughout the world need to reaffirm their commitment to stopping this devastating epidemic in its tracks.

Jay A. Levy, a professor of medicine at UC San Francisco, is an executive member of the UCSF AIDS Research Institute and was one of the first to identify the AIDS virus.


081201
SC081203


Copyright © 2008 - San Francisco Chronicle Press. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Chronicle, Permissions Desk, 901 Mission Street, San Franciso, CA 94103. You may also send a fax to (415) 495-3843, or an email message to chronperm@sfgate.com.   http://www.sfgate.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2008. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2008. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .